Demos of Altumira(TM) available at booth 7208 North Hall during RSNA 2018
STOCKHOLM – Nov. 5, 2018 – With the integration of deep learning technology, ContextVision takes digital radiography to new levels with its latest image enhancement platform, Altumira(TM).
Based upon more than 35 years of industry-leading expertise, ContextVision’s cutting-edge technology supports clinicians to accurately interpret medical imaging, leading the way to better diagnoses and improved patient care. Altumira(TM) is specially designed to meet the demanding needs of digital radiography, and addresses significant challenges regarding durability and high image quality that have been difficult to solve before, including:
- Varying exposure conditions between patients
- A wide variety of image characteristics and requirements for all types of anatomies
- Varying dose and intensity levels, as well as organs and collimators in motion in dynamic sequences
Altumira(TM) is designed for all digital radiography systems, from plain X-ray to the most advanced angiography systems.
“We can now provide greater contrast and resolution in parallel with intelligent noise suppression and harmonized intensity levels also for low-dose fluoroscopy as well as in high-quality angiography sequences,” said Ann-Sofi Hoff, Marketing and Product Portfolio Manager, ContextVision. “With our next-generation image enhancement, we’re bringing great value and confidence to both manufacturers and radiologists, providing them the highest image quality in every exam.”
This new product advances ContextVision’s present product portfolio of state-of-the-art image enhancement for 2D/3D/4D ultrasound, MRI, X-ray and mammography.
“ContextVision’s success is built on extensive technological and application knowledge paired with a broad technology platform,” said Fredrik Palm, Vice President of OEM Business, ContextVision. “Deep learning is a natural fit and we’ve now incorporated it as a core technology. We are relentless in our pursuit of R&D and product development to continuously spearhead the medical image processing and image analysis field with invaluable products.”
ContextVision is a medical technology company specializing in image analysis and artificial intelligence. Its cutting-edge technology continues to create valuable insights through intelligent imaging. The company’s product portfolio offers state-of-the-art image enhancement software for 2D/3D/4D ultrasound, MRI, radiography and mammography. The products are used by leading equipment manufacturers worldwide to produce unsurpassed image quality. All over the world, clinicians rely on ContextVision’s technology to get the answers they need from medical imaging. ContextVision is based in Sweden and listed on the Oslo Stock Exchange under the ticker COV. For more information, please visit www.contextvision.com.